Home / Respiratory system / Tezepelumab
ATC R03DX11 · Other Systemic Drugs for Obstructive Airway Diseases
Tezepelumab shortage
As of 2 Nov 2026, Tezepelumab has a reported shortage in 1 of the 15 countries we track (Canada), covering 1 product from 1 company.
Countries1/15
Products1packs or presentations
Companies11 listed
Short since–
Earliest return30 Nov 2026company estimate
Main reasonNot stated
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Which companies are short
products short, all countriesListed: AstraZeneca AZN · LSE / Nasdaq
Compared with similar medicines
ATC group R03DX · Other Systemic Drugs for Obstructive Airway DiseasesAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TEZSPIRE (Single use pre-filled syringe) discontinuation | ASTRAZENECA CANADA INC | not given | 30 Nov 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.